{"nct_id":"NCT01167166","title":"Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)","status":"COMPLETED","status_verified_date":"2017-06","start_date":"2010-07","start_date_type":null,"primary_completion_date":"2013-12","primary_completion_date_type":"ACTUAL","completion_date":"2014-06","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TRAW"]}